Literature DB >> 12884430

X-linked mild non-syndromic mental retardation with neuropsychiatric problems and the missense mutation A365E in PAK3.

Agi K Gedeon1, John Nelson, Jozef Gécz, John C Mulley.   

Abstract

We describe a family of 19 males in five generations with mild to borderline non-syndromic X-linked mental retardation (MRX). There were no clinical manifestations in the affected males other than mental impairment and relatively long ears, with neuropsychiatric problems in some cases. Linkage analysis carried out on part of the pedigree using 34 markers spanning the X chromosome localized the gene between DXS454 and DXS1001 in Xq23. The maximum two-point lod score was 3.21 at DXS1059. PAK3 is a known MRX gene mapping to the same region. The affected males and obligate carrier females were found to have a missense mutation c.1094C > A in exon 10 causing an A365E substitution in a highly conserved region of the protein. The C to A base change abolishes a PvuII restriction enzyme site providing the basis for a simple test, if required, for carrier detection and prenatal diagnosis in the extended family. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884430     DOI: 10.1002/ajmg.a.20131

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  21 in total

Review 1.  X linked mental retardation: a clinical guide.

Authors:  F L Raymond
Journal:  J Med Genet       Date:  2005-08-23       Impact factor: 6.318

Review 2.  Rho-linked genes and neurological disorders.

Authors:  Nael Nadif Kasri; Linda Van Aelst
Journal:  Pflugers Arch       Date:  2007-11-15       Impact factor: 3.657

3.  Sequence analysis of P21-activated kinase 3 (PAK3) in chronic schizophrenia with cognitive impairment.

Authors:  Eric M Morrow; Anna Kane; Donald C Goff; Christopher A Walsh
Journal:  Schizophr Res       Date:  2008-09-20       Impact factor: 4.939

4.  The p21-activated kinase PAK3 forms heterodimers with PAK1 in brain implementing trans-regulation of PAK3 activity.

Authors:  Gaëlle Combeau; Patricia Kreis; Florence Domenichini; Muriel Amar; Philippe Fossier; Véronique Rousseau; Jean-Vianney Barnier
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

5.  Array-CGH in unclear syndromic nephropathies identifies a microdeletion in Xq22.3-q23.

Authors:  Alexander Hoischen; Christina Landwehr; Sarah Kabisch; Xiao-Qi Ding; Detlef Trost; Gerhard Stropahl; Marianne Wigger; Bernhard Radlwimmer; Ruthild G Weber; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2009-05-15       Impact factor: 3.714

6.  Functional analysis of rare variants found in schizophrenia implicates a critical role for GIT1-PAK3 signaling in neuroplasticity.

Authors:  M J Kim; J Biag; D M Fass; M C Lewis; Q Zhang; M Fleishman; S P Gangwar; M Machius; M Fromer; S M Purcell; S A McCarroll; G Rudenko; R T Premont; E M Scolnick; S J Haggarty
Journal:  Mol Psychiatry       Date:  2016-07-26       Impact factor: 15.992

Review 7.  Regulation of cardiac excitation and contraction by p21 activated kinase-1.

Authors:  Yunbo Ke; Ming Lei; R John Solaro
Journal:  Prog Biophys Mol Biol       Date:  2009-01-24       Impact factor: 3.667

Review 8.  The mammalian family of sterile 20p-like protein kinases.

Authors:  Eric Delpire
Journal:  Pflugers Arch       Date:  2009-04-28       Impact factor: 3.657

9.  Characterization of oligophrenin-1, a RhoGAP lost in patients affected with mental retardation: lentiviral injection in organotypic brain slice cultures.

Authors:  Nael Nadif Kasri; Eve-Ellen Govek; Linda Van Aelst
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

Review 10.  PAK signaling in oncogenesis.

Authors:  P R Molli; D Q Li; B W Murray; S K Rayala; R Kumar
Journal:  Oncogene       Date:  2009-05-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.